{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:20:36Z","timestamp":1791300036184,"version":"4.1.0"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T00:00:00Z","timestamp":1505952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 4308"],"award-info":[{"award-number":["RG 4308"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UTSW CONQUER Project"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jaut.2017.09.002","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T02:45:12Z","timestamp":1506653112000},"page":"104-115","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model"],"prefix":"10.1016","volume":"86","author":[{"given":"Priyanka","family":"Khare","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilip K.","family":"Challa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siva Charan","family":"Devanaboyina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramraj","family":"Velmurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund J.","family":"Ober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Sally","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.09.002_bib1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.0105-2896.2005.00240.x","article-title":"Multiple sclerosis","volume":"204","author":"Hafler","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2017.09.002_bib2","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-pathol-011811-132443","article-title":"Pathology of demyelinating diseases","volume":"7","author":"Popescu","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jaut.2017.09.002_bib3","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/1531-8249(199908)46:2<144::AID-ANA3>3.0.CO;2-K","article-title":"Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation","volume":"46","author":"Raine","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2017.09.002_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib5","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1471-4159.1989.tb10930.x","article-title":"Differential ultrastructural localization of myelin basic protein, myelin\/oligodendroglial glycoprotein, and 2',3'-cyclic nucleotide 3'-phosphodiesterase in the CNS of adult rats","volume":"52","author":"Brunner","year":"1989","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jaut.2017.09.002_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1471-4159.1999.0720001.x","article-title":"The structure and function of myelin oligodendrocyte glycoprotein","volume":"72","author":"Johns","year":"1999","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.jaut.2017.09.002_bib7","doi-asserted-by":"crossref","first-page":"8207","DOI":"10.1073\/pnas.122092499","article-title":"Molecular characterization of antibody specificities against myelin\/oligodendrocyte glycoprotein in autoimmune demyelination","volume":"99","author":"von B\u00fcdingen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2017.09.002_bib8","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.4049\/jimmunol.175.3.1974","article-title":"Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein","volume":"175","author":"O'Connor","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib9","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.4049\/jimmunol.181.2.1255","article-title":"Demyelinating myelin oligodendrocyte glycoprotein-specific autoantibody response is focused on one dominant conformational epitope region in rodents","volume":"181","author":"Breithaupt","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1742-2094-8-161","article-title":"Conformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis","volume":"8","author":"Menge","year":"2011","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.jaut.2017.09.002_bib11","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jneuroim.2006.01.012","article-title":"Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: influence of relapses and immunomodulatory treatments","volume":"174","author":"Khalil","year":"2006","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.autrev.2015.12.004","article-title":"Anti-MOG antibody: the history, clinical phenotype, and pathogenicity of a serum biomarker for demyelination","volume":"15","author":"Ramanathan","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.09.002_bib13","doi-asserted-by":"crossref","first-page":"19057","DOI":"10.1073\/pnas.0607242103","article-title":"Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis","volume":"103","author":"Zhou","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2017.09.002_bib14","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.20090299","article-title":"Spontaneous relapsing-remitting EAE in the SJL\/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells","volume":"206","author":"Pollinger","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib15","doi-asserted-by":"crossref","first-page":"13992","DOI":"10.1073\/pnas.0504979102","article-title":"Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology","volume":"102","author":"Marta","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2017.09.002_bib16","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.iy.08.040190.003051","article-title":"The T lymphocyte in experimental allergic encephalomyelitis","volume":"8","author":"Zamvil","year":"1990","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib17","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1146\/annurev.immunol.20.081701.141316","article-title":"T\u00a0cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire","volume":"20","author":"Kuchroo","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib18","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1084\/jem.184.6.2271","article-title":"Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice","volume":"184","author":"Wolf","year":"1996","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1006\/jaut.2000.0371","article-title":"Relapsing and remitting experimental autoimmune encephalomyelitis in B cell deficient mice","volume":"14","author":"Dittel","year":"2000","journal-title":"J.\u00a0Autoimmun."},{"key":"10.1016\/j.jaut.2017.09.002_bib20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4049\/jimmunol.171.1.462","article-title":"Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL\/6 mice","volume":"171","author":"Oliver","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1521-4141(200207)32:7<1905::AID-IMMU1905>3.0.CO;2-L","article-title":"Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein","volume":"32","author":"Lyons","year":"2002","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.22081","article-title":"B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunity","volume":"68","author":"Weber","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jaut.2017.09.002_bib23","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2","article-title":"B\u00a0cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide","volume":"29","author":"Lyons","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib24","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1084\/jem.20130699","article-title":"MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies","volume":"210","author":"Molnarfi","year":"2013","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.4049\/jimmunol.1300019","article-title":"The encephalitogenic, human myelin oligodendrocyte glycoprotein-induced antibody repertoire is directed toward multiple epitopes in C57BL\/6-immunized mice","volume":"191","author":"Bansal","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib26","first-page":"555","article-title":"The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement","volume":"143","author":"Piddlesden","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.09.002_bib27","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1126\/science.1118948","article-title":"Divergent immunoglobulin G subclass activity through selective Fc receptor binding","volume":"310","author":"Nimmerjahn","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.jaut.2017.09.002_bib28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.immuni.2005.11.010","article-title":"Fc\u03b3 receptors: old friends and new family members","volume":"24","author":"Nimmerjahn","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jaut.2017.09.002_bib29","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1084\/jem.191.8.1293","article-title":"Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in\u00a0vivo with the low-affinity Fc\u03b3 receptor III","volume":"191","author":"Fossati-Jimack","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1365-3083.2002.01024.x","article-title":"Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis","volume":"55","author":"Abdul-Majid","year":"2002","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib31","doi-asserted-by":"crossref","first-page":"18697","DOI":"10.1073\/pnas.0607283103","article-title":"Autoantibody-mediated demyelination depends on complement activation but not activatory Fc-receptors","volume":"103","author":"Urich","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2017.09.002_bib32","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/jnen\/64.4.304","article-title":"The FcR\u03b3 chain is not essential for induction of experimental allergic encephalomyelitis (EAE) or anti-myelin antibody-mediated exacerbation of EAE","volume":"64","author":"Breij","year":"2005","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jaut.2017.09.002_bib33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri2206","article-title":"Fc\u03b3 receptors as regulators of immune responses","volume":"8","author":"Nimmerjahn","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib34","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1073\/pnas.1203954109","article-title":"Mouse model recapitulating human Fc\u03b3 receptor structural and functional diversity","volume":"109","author":"Smith","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2017.09.002_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrd2909","article-title":"Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond","volume":"11","author":"Hogarth","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jaut.2017.09.002_bib36","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.4049\/jimmunol.1101467","article-title":"Structural basis for Fc gammaRIIa recognition of human IgG and formation of inflammatory signaling complexes","volume":"187","author":"Ramsland","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib37","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1158\/1535-7163.MCT-08-0201","article-title":"Optimization of antibody binding to Fc\u03b3RIIa enhances macrophage phagocytosis of tumor cells","volume":"7","author":"Richards","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jaut.2017.09.002_bib38","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.cell.2015.04.016","article-title":"Differential Fc-receptor engagement drives an anti-tumor vaccinal effect","volume":"161","author":"DiLillo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.jaut.2017.09.002_bib39","doi-asserted-by":"crossref","first-page":"6591","DOI":"10.1074\/jbc.M009483200","article-title":"High resolution mapping of the binding site on human IgG1 for Fc\u03b3RI, Fc\u03b3RII, Fc\u03b3RIII, and FcRn and design of IgG1 variants with improved binding to the Fc\u03b3R","volume":"276","author":"Shields","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jaut.2017.09.002_bib40","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/74704","article-title":"Inhibitory Fc receptors modulate in\u00a0vivo cytoxicity against tumor targets","volume":"6","author":"Clynes","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib41","doi-asserted-by":"crossref","first-page":"12161","DOI":"10.1128\/JVI.75.24.12161-12168.2001","article-title":"Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1","volume":"75","author":"Hezareh","year":"2001","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jaut.2017.09.002_bib42","doi-asserted-by":"crossref","first-page":"4016","DOI":"10.4049\/jimmunol.139.12.4016","article-title":"A\u00a0monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease","volume":"139","author":"Schluesener","year":"1987","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib43","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1126\/science.2426778","article-title":"Three-dimensional structure of an antigen-antibody complex at 2.8 \u00c5 resolution","volume":"233","author":"Amit","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.jaut.2017.09.002_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0022-2836(92)91010-M","article-title":"Antibody framework residues affecting the conformation of the hypervariable loops","volume":"224","author":"Foote","year":"1992","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jaut.2017.09.002_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-5728(97)00019-2","article-title":"Induction of EAE in mice with recombinant human MOG, and treatment of EAE with a MOG peptide","volume":"75","author":"Devaux","year":"1997","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib46","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/abio.2002.5716","article-title":"Compensation for loss of ligand activity in surface plasmon resonance experiments","volume":"306","author":"Ober","year":"2002","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jaut.2017.09.002_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0003-2697(02)00431-1","article-title":"Analysis of exponential data using a noniterative technique: application to surface plasmon experiments","volume":"312","author":"Ober","year":"2003","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.jaut.2017.09.002_bib48","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4049\/jimmunol.178.1.134","article-title":"Feedback regulation of murine autoimmunity via dominant anti-inflammatory effects of interferon \u03b3","volume":"178","author":"Minguela","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib49","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-3083.1994.tb03488.x","article-title":"Catabolism of the murine IgG1 molecule: evidence that both CH2-CH3 domain interfaces are required for persistence of IgG1 in the circulation of mice","volume":"40","author":"Kim","year":"1994","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.4161\/mabs.25439","article-title":"Autoantibody depletion ameliorates disease in murine experimental autoimmune encephalomyelitis","volume":"5","author":"Challa","year":"2013","journal-title":"MAbs"},{"key":"10.1016\/j.jaut.2017.09.002_bib51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1084\/jem.193.6.713","article-title":"Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis","volume":"193","author":"Huang","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.jaut.2017.09.002_bib52","doi-asserted-by":"crossref","first-page":"9446","DOI":"10.1073\/pnas.1133443100","article-title":"Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein","volume":"100","author":"Breithaupt","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2017.09.002_bib53","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1212\/NXI.0000000000000089","article-title":"MOG cell-based assay detects non-MS patients with inflammatory neurologic disease","volume":"2","author":"Waters","year":"2015","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.jaut.2017.09.002_bib54","doi-asserted-by":"crossref","first-page":"6664","DOI":"10.4049\/jimmunol.181.9.6664","article-title":"Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions","volume":"181","author":"Baudino","year":"2008","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib55","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.4049\/jimmunol.164.8.4178","article-title":"Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc","volume":"164","author":"Idusogie","year":"2000","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib56","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.4049\/jimmunol.1003926","article-title":"Epidermal growth factor receptor (EGFR) antibody-induced antibody-dependent cellular cytotoxicity plays a prominent role in inhibiting tumorigenesis, even of tumor cells insensitive to EGFR signaling inhibition","volume":"187","author":"Overdijk","year":"2011","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib57","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/imr.12350","article-title":"Mouse and human FcR effector functions","volume":"268","author":"Bruhns","year":"2015","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jaut.2017.09.002_bib58","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1073\/pnas.0810796106","article-title":"Conditional deletion of the MHC Class I-related receptor, FcRn, reveals the sites of IgG homeostasis in mice","volume":"106","author":"Perez-Montoyo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.jaut.2017.09.002_bib59","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12974-015-0450-1","article-title":"Pro-inflammatory pattern of IgG1 Fc glycosylation in multiple sclerosis cerebrospinal fluid","volume":"12","author":"Wuhrer","year":"2015","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.jaut.2017.09.002_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1742-2094-9-209","article-title":"IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis","volume":"9","author":"Benkhoucha","year":"2012","journal-title":"J.\u00a0Neuroinflamm."},{"key":"10.1016\/j.jaut.2017.09.002_bib61","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2013.05.010","article-title":"Exacerbation of experimental autoimmune encephalomyelitis by passive transfer of IgG antibodies from a multiple sclerosis patient responsive to immunoadsorption","volume":"262","author":"Pedotti","year":"2013","journal-title":"J.\u00a0Neuroimmunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib62","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/aws105","article-title":"Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis","volume":"135","author":"Elliott","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.jaut.2017.09.002_bib63","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.4049\/jimmunol.1301296","article-title":"Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases","volume":"191","author":"Mayer","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib64","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.4049\/jimmunol.0801888","article-title":"Age-dependent B cell autoimmunity to a myelin surface antigen in pediatric multiple sclerosis","volume":"183","author":"McLaughlin","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib65","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1212\/WNL.0b013e318228c0b1","article-title":"Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis","volume":"77","author":"Probstel","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.jaut.2017.09.002_bib66","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.4049\/jimmunol.176.3.1305","article-title":"The central role of the alternative complement pathway in human disease","volume":"176","author":"Thurman","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib67","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.4049\/jimmunol.1200501","article-title":"Impact of immune complex size and glycosylation on IgG binding to human Fc\u03b3Rs","volume":"190","author":"Lux","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib68","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.4049\/jimmunol.1202613","article-title":"Neutrophils amplify autoimmune central nervous system infiltrates by maturing local APCs","volume":"191","author":"Steinbach","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.09.002_bib69","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.1182\/blood-2012-01-380121","article-title":"Properties of mouse and human IgG receptors and their contribution to disease models","volume":"119","author":"Bruhns","year":"2012","journal-title":"Blood"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117301555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117301555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:16:30Z","timestamp":1760256990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117301555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":69,"alternative-id":["S0896841117301555"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.09.002","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Myelin oligodendrocyte glycoprotein-specific antibodies from multiple sclerosis patients exacerbate disease in a humanized mouse model","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}